204 related articles for article (PubMed ID: 25678784)
1. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
[TBL] [Abstract][Full Text] [Related]
3. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.
Bhavsar P; Khorasani N; Hew M; Johnson M; Chung KF
Eur Respir J; 2010 Apr; 35(4):750-6. PubMed ID: 19840967
[TBL] [Abstract][Full Text] [Related]
4. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
[TBL] [Abstract][Full Text] [Related]
5. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
[TBL] [Abstract][Full Text] [Related]
6. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma.
Mercado N; Hakim A; Kobayashi Y; Meah S; Usmani OS; Chung KF; Barnes PJ; Ito K
PLoS One; 2012; 7(7):e41582. PubMed ID: 22911818
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
Kent LM; Smyth LJ; Plumb J; Clayton CL; Fox SM; Ray DW; Farrow SN; Singh D
J Pharmacol Exp Ther; 2009 Feb; 328(2):458-68. PubMed ID: 19004925
[TBL] [Abstract][Full Text] [Related]
8. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.
Irusen E; Matthews JG; Takahashi A; Barnes PJ; Chung KF; Adcock IM
J Allergy Clin Immunol; 2002 Apr; 109(4):649-57. PubMed ID: 11941315
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
Milara J; Lluch J; Almudever P; Freire J; Xiaozhong Q; Cortijo J
J Allergy Clin Immunol; 2014 Aug; 134(2):314-22. PubMed ID: 24636089
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Lea S; Harbron C; Khan N; Booth G; Armstrong J; Singh D
Br J Clin Pharmacol; 2015 May; 79(5):756-66. PubMed ID: 25358442
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
Higham A; Lea S; Ray D; Singh D
J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
Khalaf RM; Lea SR; Metcalfe HJ; Singh D
Respir Res; 2017 Apr; 18(1):61. PubMed ID: 28420398
[TBL] [Abstract][Full Text] [Related]
13. Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.
Mitani A; Ito K; Vuppusetty C; Barnes PJ; Mercado N
Am J Respir Crit Care Med; 2016 Jan; 193(2):143-53. PubMed ID: 26426522
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.
Milara J; Morell A; Ballester B; Sanz C; Freire J; Qian X; Alonso-Garcia M; Morcillo E; Cortijo J
Respir Res; 2015 Feb; 16(1):12. PubMed ID: 25652132
[TBL] [Abstract][Full Text] [Related]
15. p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma.
Mercado N; To Y; Kobayashi Y; Adcock IM; Barnes PJ; Ito K
Mol Pharmacol; 2011 Dec; 80(6):1128-35. PubMed ID: 21917909
[TBL] [Abstract][Full Text] [Related]
16. Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma.
Kobayashi Y; Mercado N; Barnes PJ; Ito K
PLoS One; 2011; 6(12):e27627. PubMed ID: 22205926
[TBL] [Abstract][Full Text] [Related]
17. Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.
Sun XJ; Li ZH; Zhang Y; Zhou G; Zhang JQ; Deng JM; Bai J; Liu GN; Li MH; MacNee W; Zhong XN; He ZY
Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L139-46. PubMed ID: 25957293
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition.
Rossios C; To Y; Osoata G; Ito M; Barnes PJ; Ito K
Br J Pharmacol; 2012 Oct; 167(4):775-86. PubMed ID: 22251095
[TBL] [Abstract][Full Text] [Related]
19. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
[TBL] [Abstract][Full Text] [Related]
20. Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD.
Haque R; Hakim A; Moodley T; Torrego A; Essilfie-Quaye S; Jazrawi E; Johnson M; Barnes PJ; Adcock IM; Usmani OS
J Allergy Clin Immunol; 2013 Nov; 132(5):1166-73. PubMed ID: 24070494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
